Semaglutide Reduces Need for Diuretics in Heart Failure
By Lori Solomon HealthDay Reporter
THURSDAY, May 16, 2024 -- Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF), regardless of diuretic use, according to a study presented at the European Society of Cardiology Heart Failure 2024, held from May 11 to 14 in Lisbon, Portugal.
Kavita Sharma, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues used data from 1,145 participants in a multisite, international trial, in which participants with obesity-related HFpEF were randomly assigned (1:1) to once-weekly semaglutide (2.4 mg) or placebo for 52 weeks.
The researchers found that semaglutide improved the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score in all diuretic subgroups, but the magnitude of improvement was greater in patients receiving loop diuretics versus those not on loop diuretics (adjusted mean difference of 9.3 versus 4.7 points, respectively). Semaglutide had a consistent beneficial effect on percentage change in body weight across diuretic use categories (adjusted mean difference ranged from −8.8 to −6.9 percent for no diuretics to the highest loop diuretic dose category). There were consistent beneficial effects for semaglutide on all secondary efficacy end points (including six-minute walk distance) across diuretic subgroups.
"There was evidence of a significant reduction in average loop diuretic dose, a lower likelihood of diuretic treatment escalation, and a greater likelihood of diuretic treatment de-escalation with semaglutide versus placebo -- parameters that indicate disease-modifying effects of semaglutide -- and are associated with better long-term clinical outcomes in this patient population," Sharma said in a statement.
The study was funded by Novo Nordisk, and one author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
Heart Failure Tied to Worsening of Neuropsychological Symptoms
TUESDAY, April 22, 2025 -- Patients with heart failure experience worsening neuropsychological outcomes over six months, according to a study published online April 8...
Poor Hearing Associated With Increased Risk for Incident Heart Failure
THURSDAY, April 10, 2025 -- Poor hearing is associated with an increased risk for incident heart failure, which is partially mediated by psychological distress, according to a...
ACC: Bilateral Oophorectomy Linked to Increased Risk for Heart Failure
FRIDAY, March 28, 2025 -- Bilateral oophorectomy is associated with an increased risk for heart failure, with a greater risk seen with younger age and for White women, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.